We are live on
!
Find out more
LSV Asset Management Portfolio holdings
AUM
$55.1B
1-Year Est. Return
45.38%
This Fund
S&P 500
This Quarter
Est. Return
+6.82%
1 Year Est. Return
+45.38%
3 Year Est. Return
+99.45%
5 Year Est. Return
+122.42%
10 Year Est. Return
+379.58%
AUM
$63.4B
AUM Growth
+$2.73B
(+4.5%)
Cap. Flow
-$842M
Cap. Flow
% of AUM
-1.33%
Top 10 Holdings %
Top 10 Hldgs %
16.01%
Holding
1,043
New
44
Increased
312
Reduced
417
Closed
60
Avg Time Held
11.5
quarters
Top 10 Avg Time Held
10.7
quarters
Top 20 Avg Time Held
10.5
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walgreens Boots Alliance
WBA
|
+$258M |
| 2 |
Campbell Soup
CPB
|
+$101M |
| 3 |
Ingredion
INGR
|
+$100M |
| 4 |
Kellanova
K
|
+$75.1M |
| 5 |
J.M. Smucker
SJM
|
+$71.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$379M |
| 2 |
Boeing
BA
|
+$228M |
| 3 |
Qualcomm
QCOM
|
+$193M |
| 4 |
OA
Orbital ATK, Inc.
OA
|
+$109M |
| 5 |
Packaging Corp of America
PKG
|
+$103M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 25.09% |
| 2 | Technology | 13.85% |
| 3 | Healthcare | 12.91% |
| 4 | Consumer Discretionary | 10.68% |
| 5 | Industrials | 10.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Johnson & Johnson
JNJ
$633B
| $1.28B | 2.03% |
9,188,773
-629,724
| -6% | -$87.7M |
2013 Q2
18 quarters
|
|
2
JPMorgan Chase
JPM
$890B
| $1.26B | 1.99% |
11,803,866
-541,502
| -4% | -$54.8M |
2013 Q2
18 quarters
|
|
3
Pfizer
PFE
$162B
| $1.24B | 1.96% |
36,216,169
-86,620
| -0.2% | -$2.95M |
2013 Q2
18 quarters
|
|
4
Intel
INTC
$535B
| $1.12B | 1.77% |
24,277,592
+410,684
| +2% | +$17.9M |
2013 Q2
18 quarters
|
|
5
Cisco
CSCO
$453B
| $1.05B | 1.66% |
27,511,862
-462,843
| -2% | -$16.5M |
2013 Q2
18 quarters
|
|
6
Citigroup
C
$219B
| $965M | 1.52% |
12,962,004
-550,100
| -4% | -$40.7M |
2013 Q2
18 quarters
|
|
7
Bank of America
BAC
$381B
| $876M | 1.38% |
29,670,945
-781,498
| -3% | -$21.5M |
2013 Q2
18 quarters
|
|
8
Valero Energy
VLO
$126B
| $817M | 1.29% |
8,892,712
-341,169
| -4% | -$28.1M |
2013 Q2
18 quarters
|
|
9
AT&T
T
$154B
| $776M | 1.22% |
26,412,771
-820,384
| -3% | -$22.4M |
2013 Q2
18 quarters
|
|
10
Verizon
VZ
$176B
| $747M | 1.18% |
14,115,327
+729,841
| +5% | +$35.9M |
2013 Q2
18 quarters
|
|
11
Public Service Enterprise Group
PEG
$35.4B
| $715M | 1.13% |
13,874,287
-226,962
| -2% | -$11.4M |
2013 Q2
18 quarters
|
|
12
ExxonMobil
XOM
$706B
| $702M | 1.11% |
8,393,664
-111,610
| -1% | -$9.23M |
2013 Q2
18 quarters
|
|
13
Amgen
AMGN
$225B
| $663M | 1.05% |
3,814,771
+234,461
| +7% | +$41.5M |
2013 Q2
18 quarters
|
|
14
Chevron
CVX
$421B
| $612M | 0.97% |
4,890,761
-109,190
| -2% | -$12.9M |
2013 Q2
18 quarters
|
|
15
AbbVie
ABBV
$494B
| $611M | 0.96% |
6,319,303
-523,470
| -8% | -$49.3M |
2013 Q2
18 quarters
|
|
16
Elevance Health
ELV
$91.3B
| $556M | 0.88% |
2,472,099
-235,429
| -9% | -$50.1M |
2013 Q2
18 quarters
|
|
17
Merck
MRK
$359B
| $541M | 0.85% |
10,070,337
-363,486
| -3% | -$20.2M |
2013 Q2
18 quarters
|
|
18
Allstate
ALL
$58.9B
| $531M | 0.84% |
5,069,858
-255,850
| -5% | -$25.2M |
2013 Q2
18 quarters
|
|
19
DELISTED
Discover Financial Services
DFS
| $531M | 0.84% |
6,898,150
+234,467
| +4% | +$16.1M |
2013 Q2
18 quarters
|
|
|
20
Boeing
BA
$151B
| $528M | 0.83% |
1,789,611
-843,320
| -32% | -$228M |
2013 Q2
18 quarters
|
|
21
Travelers Companies
TRV
$77.3B
| $503M | 0.79% |
3,709,428
-273,227
| -7% | -$36.1M |
2013 Q2
18 quarters
|
|
22
Regions Financial
RF
$23.2B
| $497M | 0.79% |
28,780,094
-533,189
| -2% | -$8.53M |
2013 Q2
18 quarters
|
|
23
Walmart Inc
WMT
$890B
| $488M | 0.77% |
14,817,630
-371,973
| -2% | -$11.4M |
2013 Q2
18 quarters
|
|
24
Capital One
COF
$123B
| $475M | 0.75% |
4,774,254
+557,665
| +13% | +$50.9M |
2013 Q2
18 quarters
|
|
25
Ameriprise Financial
AMP
$44.4B
| $474M | 0.75% |
2,794,674
-28,825
| -1% | -$4.62M |
2013 Q2
18 quarters
|
|
Similar funds
HF
LSV Asset Management's Q4 2017 Portfolio in Review
As of Q4 2017, LSV Asset Management held 1,043 positions worth $63.4B, up 4.5% from $60.6B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
LSV Asset Management's Q4 2017 filing shows 44 new, 312 increased, 417 reduced and 60 closed positions. Its largest new stake was Kellanova: 1,247,009 shares worth $79.6M. The largest sale was CVS Health, an estimated $379M.
By sector, the portfolio is most concentrated in Financials at 25% of assets, up from 25% a quarter earlier, followed by Technology and Healthcare.
- LSV Asset Management's largest Q4 2017 buy was Kellanova: 1,247,009 shares worth $79.6M.
- LSV Asset Management added most to Walgreens Boots Alliance in Q4 2017, an estimated $258M increase.
- LSV Asset Management's biggest Q4 2017 reduction was CVS Health, cutting an estimated $379M.
- LSV Asset Management fully exited Brocade Communications Systems, Inc. NEW in Q4 2017, selling an estimated $21.7M.
- LSV Asset Management's ten largest holdings make up 16% of its $63.4B portfolio in Q4 2017.
- LSV Asset Management opened 44 new positions and closed 60 in Q4 2017.
- LSV Asset Management's portfolio value rose 4.5% quarter-over-quarter to $63.4B.
Based on LSV Asset Management's 13F filing for Q4 2017, filed 1 Feb 2018.